Publicação
Internship Reports and Monograph Entitled"The Role Of Gender-Affirming Therapy In Mental Health Improvement"
| Resumo: | Transgender populations (TP) are at higher risk of suffering from poor healthcare treatment and inequalities. The high prevalence of adverse health outcomes among TP is a significant concern in public health. Therefore, studies consistently document that these individuals face increased risks for various health issues, including mental health disorders.Transgender is a term that encompasses a wide range of individuals, who unlike their cisgender counterparts, do not align their self-identified gender with their sex assignment at birth. As result, they are more likely to experience Gender Dysmorphia or also known as Gender Incongruence and Prejudice. Having someone's gender identity recognised and respected by others is part of the Gender Affirmation Journey. Even so, it does not only include social recognition, but also medical interventions such as hormonal therapy, surgical interventions and legal factors like name changes. In Portugal, the Transgender Community has access to gender-affirming therapy through the public health care system, are protected under anti-discrimination laws and holds the legal right to change both name and gender on official documents. The studies being conducted show that transgender people are more likely than cisgender people to experience depression and anxiety before gender-affirming hormone treatment (GAHT). However, the effect of GAHT on mental health in transgender people, and the role of other factors that may have a predictive effect, is poorly explored, and experimental studies must be conducted to bring awareness and valuable information to the scientific community. This overview of existing literature suggests that gender-affirming hormone therapy is linked to psychological benefits, including reductions in depression and anxiety, and improvements in quality of life (QOL) among transgender individuals. |
|---|---|
| Autores principais: | Lopes, Inês Pinto |
| Assunto: | Transgender Gender-Affirming Therapy Gonadotropin-Releasing Hormone Agonists Mental Health Gender-Diverse Transgénero Terapia de Afirmação de Género Agonistas da hormona libertadora de gonadotrofina Saúde Mental Diversidade de Género |
| Ano: | 2025 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso embargado |
| Instituição associada: | Universidade de Coimbra |
| Idioma: | inglês |
| Origem: | Estudo Geral - Universidade de Coimbra |
| Resumo: | Transgender populations (TP) are at higher risk of suffering from poor healthcare treatment and inequalities. The high prevalence of adverse health outcomes among TP is a significant concern in public health. Therefore, studies consistently document that these individuals face increased risks for various health issues, including mental health disorders.Transgender is a term that encompasses a wide range of individuals, who unlike their cisgender counterparts, do not align their self-identified gender with their sex assignment at birth. As result, they are more likely to experience Gender Dysmorphia or also known as Gender Incongruence and Prejudice. Having someone's gender identity recognised and respected by others is part of the Gender Affirmation Journey. Even so, it does not only include social recognition, but also medical interventions such as hormonal therapy, surgical interventions and legal factors like name changes. In Portugal, the Transgender Community has access to gender-affirming therapy through the public health care system, are protected under anti-discrimination laws and holds the legal right to change both name and gender on official documents. The studies being conducted show that transgender people are more likely than cisgender people to experience depression and anxiety before gender-affirming hormone treatment (GAHT). However, the effect of GAHT on mental health in transgender people, and the role of other factors that may have a predictive effect, is poorly explored, and experimental studies must be conducted to bring awareness and valuable information to the scientific community. This overview of existing literature suggests that gender-affirming hormone therapy is linked to psychological benefits, including reductions in depression and anxiety, and improvements in quality of life (QOL) among transgender individuals. |
|---|